.Nature Medication, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medicine conjugate (ADC) tisotumab vedotin caused enhanced progression-free and overall survival, causing FDA approval as well as a brand-new therapy alternative for people.